Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) - Mavaddat, N; Barrowdale, D; Andrulis, IL (Cancer Epidemiol Biomarkers Prev, 2012)